Ovarian cancer cells with elevated levels of αvβ6 showed in vitro a higher expression of urokinase-type plasminogen activator (uPA), uPA-receptor (uPAR) and matrix metalloproteinases (MMP) such as MMP-2 and MMP-9 [148]. Here, PLAU is linked to ovarian carcinoma.